Spectrophotometric Estimation of Olmesartan Medoxomil and Hydrochlorothiazide in Tablet

A simultaneous determination of olmesartan medoxomil and hydrochlorothiazide by absorption ratio spectrophotometric method has been developed in combined tablet dosage form. The method is based on measurements of absorbance at isoabsoptive point. The Beer's law obeys in the range of 10–30 μg/ml...

Descripción completa

Detalles Bibliográficos
Autores principales: Rote, A. R., Bari, P. D.
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883210/
https://www.ncbi.nlm.nih.gov/pubmed/20582200
http://dx.doi.org/10.4103/0250-474X.62245
_version_ 1782182243786031104
author Rote, A. R.
Bari, P. D.
author_facet Rote, A. R.
Bari, P. D.
author_sort Rote, A. R.
collection PubMed
description A simultaneous determination of olmesartan medoxomil and hydrochlorothiazide by absorption ratio spectrophotometric method has been developed in combined tablet dosage form. The method is based on measurements of absorbance at isoabsoptive point. The Beer's law obeys in the range of 10–30 μg/ml for both olmesartan medoxomil and hydrochlorothiazide respectively. The proposed method was validated by performing recovery study and statistically.
format Text
id pubmed-2883210
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-28832102010-06-25 Spectrophotometric Estimation of Olmesartan Medoxomil and Hydrochlorothiazide in Tablet Rote, A. R. Bari, P. D. Indian J Pharm Sci Short Communication A simultaneous determination of olmesartan medoxomil and hydrochlorothiazide by absorption ratio spectrophotometric method has been developed in combined tablet dosage form. The method is based on measurements of absorbance at isoabsoptive point. The Beer's law obeys in the range of 10–30 μg/ml for both olmesartan medoxomil and hydrochlorothiazide respectively. The proposed method was validated by performing recovery study and statistically. Medknow Publications 2010 /pmc/articles/PMC2883210/ /pubmed/20582200 http://dx.doi.org/10.4103/0250-474X.62245 Text en © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Rote, A. R.
Bari, P. D.
Spectrophotometric Estimation of Olmesartan Medoxomil and Hydrochlorothiazide in Tablet
title Spectrophotometric Estimation of Olmesartan Medoxomil and Hydrochlorothiazide in Tablet
title_full Spectrophotometric Estimation of Olmesartan Medoxomil and Hydrochlorothiazide in Tablet
title_fullStr Spectrophotometric Estimation of Olmesartan Medoxomil and Hydrochlorothiazide in Tablet
title_full_unstemmed Spectrophotometric Estimation of Olmesartan Medoxomil and Hydrochlorothiazide in Tablet
title_short Spectrophotometric Estimation of Olmesartan Medoxomil and Hydrochlorothiazide in Tablet
title_sort spectrophotometric estimation of olmesartan medoxomil and hydrochlorothiazide in tablet
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883210/
https://www.ncbi.nlm.nih.gov/pubmed/20582200
http://dx.doi.org/10.4103/0250-474X.62245
work_keys_str_mv AT rotear spectrophotometricestimationofolmesartanmedoxomilandhydrochlorothiazideintablet
AT baripd spectrophotometricestimationofolmesartanmedoxomilandhydrochlorothiazideintablet

Ejemplares similares